Viewing Study NCT01397305


Ignite Creation Date: 2025-12-25 @ 3:22 AM
Ignite Modification Date: 2026-02-06 @ 6:04 AM
Study NCT ID: NCT01397305
Status: COMPLETED
Last Update Posted: 2020-09-09
First Post: 2011-05-25
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: An Extended Feasibility Phase I/II Study of Methylenetetrahydrofolate (Arfolitixorin) and Pemetrexed Single Agent, Given as Neoadjuvant Treatment in Patients With Resectable Rectal Cancer
Sponsor:
Organization: